Displaying 1 - 1 of 1
| Active Ingredient | METHYLPHENIDATE |
| Therapeutic Class | RESPIRATORY-CEREBRAL STIMULANTS |
| Indications | Attention deficit disorders; narcolepsy . |
| Caution | Restlessness, vertigo, physical dependence, slurred speech. |
| Dose Range |
Narcolepsy: 10-60mg daily in 2-3 divided doses 30-45 minutes before meals. Hyperkinetic states: Pediatric 6 and over: 5mg twice daily (immediate-release) before breakfast and lunch increased if necessary to 60mg daily . |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |